These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18574359)

  • 41. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain.
    Passik SD; Messina J; Golsorkhi A; Xie F
    J Pain Symptom Manage; 2011 Jan; 41(1):116-25. PubMed ID: 20580202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain.
    Chaudhary S; Compton P
    Subst Abus; 2017; 38(1):95-104. PubMed ID: 27897471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonopioid substance use disorders and opioid dose predict therapeutic opioid addiction.
    Huffman KL; Shella ER; Sweis G; Griffith SD; Scheman J; Covington EC
    J Pain; 2015 Feb; 16(2):126-34. PubMed ID: 25463699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eight principles for safer opioid prescribing and cautions with benzodiazepines.
    Webster LR; Reisfield GM; Dasgupta N
    Postgrad Med; 2015 Jan; 127(1):27-32. PubMed ID: 25526233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
    Butler SF; Budman SH; Fanciullo GJ; Jamison RN
    Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.
    Katz NP; Sherburne S; Beach M; Rose RJ; Vielguth J; Bradley J; Fanciullo GJ
    Anesth Analg; 2003 Oct; 97(4):1097-1102. PubMed ID: 14500164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review.
    Balbale SN; Trivedi I; O'Dwyer LC; McHugh MC; Evans CT; Jordan N; Keefer LA
    Dig Dis Sci; 2017 Oct; 62(10):2668-2685. PubMed ID: 28780607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioids in the management of HIV-related pain.
    Krashin DL; Merrill JO; Trescot AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES157-68. PubMed ID: 22786454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review.
    Minozzi S; Amato L; Davoli M
    Addiction; 2013 Apr; 108(4):688-98. PubMed ID: 22775332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic risk factors in the misuse of opioid analgesics.
    Pergolizzi JV; Gharibo C; Passik S; Labhsetwar S; Taylor R; Pergolizzi JS; Müller-Schwefe G
    J Psychosom Res; 2012 Jun; 72(6):443-51. PubMed ID: 22656441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychology's role in addressing the dual crises of chronic pain and opioid-related harms: Introduction to the special issue.
    Palermo TM; Kerns RD
    Am Psychol; 2020 Sep; 75(6):741-747. PubMed ID: 32915019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Issues in long-term opioid therapy: unmet needs, risks, and solutions.
    Passik SD
    Mayo Clin Proc; 2009 Jul; 84(7):593-601. PubMed ID: 19567713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview.
    Jones T; Moore T
    J Opioid Manag; 2013; 9(1):19-27. PubMed ID: 23709300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioids in chronic noncancer pain.
    Manchikanti L; Benyamin R; Datta S; Vallejo R; Smith H
    Expert Rev Neurother; 2010 May; 10(5):775-89. PubMed ID: 20420496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases].
    Wambach S; Rohr P; Häuser W
    Schmerz; 2001 Aug; 15(4):254-64. PubMed ID: 11810364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature.
    Reisfield GM; Wasan AD; Jamison RN
    Pain Med; 2009 Nov; 10(8):1434-41. PubMed ID: 19793342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.